Michael Ball New CEO of GenoLogics, Steven Gullans Leaves US Genomics to Head RxGen, Hans Johansson Joins Sidec Technologies as CEO, Robert Millman Becomes Chief Patent Counsel of Alnylam, and Others

genomeweb
360dx

Michael Ball New CEO of GenoLogics, Steven Gullans Leaves US Genomics to Head RxGen, Hans Johansson Joins Sidec Technologies as CEO, Robert Millman Becomes Chief Patent Counsel of Alnylam, and Others

Sep 15, 2004

Michael Ball has become the new CEO of GenoLogics, the Victoria, Canada-based company said on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Glaucoma Risk Factor Linked to More Than 100 Genetic Loci in Europeans
Pfizer to Offer $1.5M in Grant Funding to Support BRCA Testing
Human Malaria Parasite's Evolution Refined by Genomes of Great Ape Pathogens
Foundation Medicine's Stock Rises on Approval of Test as New ADLT
IncellDx Gets CE Mark for HPV Assay
Top Five Articles on GenomeWeb Last Week: Illumina, 23andMe, Siemens Healthineers, and More

The Scan

New Nature EIC Talks Transparency

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic Genealogy for Another Arrest

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

This Week in PLOS

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Working With Others

Wired reports that 23andMe is trying to bolster its outside collaborations.

Main menu